Skip to content

Telemonitoring in Arterial Hypertension

Randomized Trial for Telemedical Support Versus Standard Treatment to Control Arterial Hypertension

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07049289
Acronym
REMOTE-Control
Enrollment
60
Registered
2025-07-03
Start date
2023-12-13
Completion date
2025-09-09
Last updated
2025-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arterial Hypertension, Uncontrolled Hypertension

Brief summary

Prospective, randomized trial to assess the effects of a telemedical approach of antihypertensive treatment in comparison with standard care. Total patient number: 60 patients. * Intervention group: biweekly telephone calls * Control group: standard of care

Interventions

OTHERTelemonitoring

Patients randomized to intervention group will receive biweeky telephone calls and adaption of antiyhpertensive medication if needed

Sponsors

Heart Center Leipzig - University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Confirmed arterial hypertension with systolic or diastolic blood pressure \>140/90 mmHg in standardized office blood pressure measurement 2. Treatment with 1 to ≤4 antihypertensive drug classes 3. Age \>18 years 4. Written informed consent

Exclusion criteria

1. Pregnancy 2. Participation in other randomized trials 3. Patients under legal supervision or guardianship

Design outcomes

Primary

MeasureTime frameDescription
Time in blood pressure target range from randomization through 6 months6 monthsTime in target range of each blood pressure measurement in first 6 months between control and intervention group

Secondary

MeasureTime frameDescription
Time in target range months 6 to 126 months (7-12 months)Time in target range of each blood pressure measurement between control and intervention group from months 7 to 12
Medication adherence as assessed by blood/urine sampling after 6 and 12 months0, 6 and 12 monthsMedication adherence as assessed by blood/urine sampling after 6 and 12 months

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026